PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.01%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.20%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.60%
Negative net income growth while VTLE stands at 28.56%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.98%
Negative EPS growth while VTLE is at 29.94%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.13%
Negative diluted EPS growth while VTLE is at 30.30%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.83%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.69%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-5.60%
Dividend reduction while VTLE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-28.42%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
101.88%
10Y revenue/share CAGR above 1.5x VTLE's 16.72%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
217.71%
5Y revenue/share CAGR above 1.5x VTLE's 62.05%. David Dodd would look for consistent product or market expansions fueling outperformance.
98.77%
3Y revenue/share CAGR 1.25-1.5x VTLE's 66.70%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-50.89%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
107.70%
5Y OCF/share CAGR above 1.5x VTLE's 13.39%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
33.35%
3Y OCF/share CAGR above 1.5x VTLE's 19.63%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
155.59%
Below 50% of VTLE's 1763.45%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
210.93%
Below 50% of VTLE's 1577.74%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
734.12%
3Y net income/share CAGR above 1.5x VTLE's 188.68%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-30.80%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-27.52%
Negative 5Y equity/share growth while VTLE is at 107.70%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-30.81%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-76.47%
Cut dividends over 10 years while VTLE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
226.56%
Dividend/share CAGR of 226.56% while VTLE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
158.99%
3Y dividend/share CAGR of 158.99% while VTLE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-16.39%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
100.00%
Inventory shrinking or stable vs. VTLE's 267.03%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-3.68%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
14.62%
Under 50% of VTLE's 48.90%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
9.78%
We expand SG&A while VTLE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.